The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women
Open accessAbstract
Human papillomavirus (HPV) is a necessary cause of cervical cancer. In addition, on the basis of the fulfillment of a combination of viral as well as epidemiological criteria, it is currently accepted that a proportion of anal, oropharyngeal, vulvar, and vaginal cancers among women and anal, oropharyngeal, and penile cancers among men are etiologically related to HPV. At these noncervical sites with etiologic heterogeneity, HPV-associated cancers represent a distinct clinicopathological entity, which is generally characterized by a younger age at onset, basaloid or warty histopathology, association with sexual behavior, and better prognosis, when compared with their HPV-negative counterparts. Currently available estimates indicate that the number of HPV-associated noncervical cancers diagnosed annually in the US roughly approximates the number of cervical cancers, with an equal number of noncervical cancers among men and women. Furthermore, whereas the incidence of cervical cancers has been decreasing over time, the incidence of anal and oropharyngeal cancers, for which there are no effective or widely used screening programs, has been increasing in the US. The efficacy of HPV vaccines in preventing infection at sites other than the cervix, vagina, and vulva should, therefore, be assessed (eg, oral and anal). Given that a substantial proportion of cervical cancers (approximately 70%) and an even greater proportion of HPV-associated noncervical cancers (approximately 86% to 95%) are caused by HPV16 and 18 (HPV types that are targeted by the currently available vaccines), current HPV vaccines may hold great promise (provided equivalent efficacy at all relevant anatomic sites) in reducing the burden of HPV-associated noncervical cancers, in addition to cervical cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Gillison, M. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.709 · Cited by 3,101
Self-citationHuman papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Fakhry, C., Westra, W. H., Li, S., Cmelak, A., Ridge, J. A., Pinto, H., Forastiere, A., & Gillison, M. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn011 · Cited by 2,779
Self-citationCase–Control Study of Human Papillomavirus and Oropharyngeal Cancer
D'Souza, G., Kreimer, A. R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W. M., Westra, W. H., & Gillison, M. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065497 · Cited by 2,692
Self-citationHuman Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0551 · Cited by 2,184
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Head and neck squamous cell carcinoma
Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00224-3 · Cited by 4,067
Jemal, A., Simard, E. P., Dorell, C., Noone, A.-M., Markowitz, L. E., Kohler, B., Eheman, C., Saraiya, M., Bandi, P., Saslow, D., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs491 · Cited by 993
Holman, D. M., Benard, V., Roland, K. B., Watson, M., Liddon, N., & Stokley, S. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.2752 · Cited by 863
DeSantis, C. E., Siegel, R. L., Sauer, A. G., Miller, K. D., Fedewa, S. A., Alcaraz, K. I., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21340 · Cited by 790
US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., Watson, M., Wilkinson, E. J., Hopenhayn, C., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv086 · Cited by 761
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747
Herrero, R., Quint, W., Hildesheim, A., Gonzalez, P., Struijk, L., Katki, H. A., Porras, C., Schiffman, M., Rodriguez, A. C., Solomon, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068329 · Cited by 473
Self-citationCancer statistics for Hispanics/Latinos, 2015
Siegel, R. L., Fedewa, S. A., Miller, K. D., Goding‐Sauer, A., Pinheiro, P. S., Martinez‐Tyson, D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21314 · Cited by 468
Beyond Cervical Cancer: Burden of Other HPV-Related Cancers Among Men and Women
Chaturvedi, A. K. (2010) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2010.01.016 · Cited by 361
Self-citationOpportunities and challenges for human papillomavirus vaccination in cancer
Roden, R. B. S., & Stern, P. L. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.13 · Cited by 333
Simard, E. P., Torre, L. A., & Jemal, A. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.01.016 · Cited by 304
Epidemiology and Clinical Aspects of HPV in Head and Neck Cancers
Chaturvedi, A. K. (2012) · Head and Neck Pathology · doi:10.1007/s12105-012-0377-0 · Cited by 274
Self-citationYeo-Teh, N. S. L., Ito, Y., & Jha, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061706 · Cited by 273
The role of HPV in head and neck cancer and review of the HPV vaccine
D'Souza, G., & Dempsey, A. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.001 · Cited by 267
Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261
Human papillomavirus molecular biology
Harden, M. E., & Munger, K. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.07.002 · Cited by 260
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Self-citationPrevalence of major risk factors and use of screening tests for cancer in the United States
Fedewa, S. A., Sauer, A. G., Siegel, R. L., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0134 · Cited by 77
Reiter, P. L., & McRee, A.-L. (2015) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2014-101004 · Cited by 59
Paz-Zulueta, M., Álvarez-Paredes, L., Rodríguez Díaz, J. C., Parás-Bravo, P., Andrada Becerra, M. E., Rodríguez Ingelmo, J. M., Ruiz García, M. M., Portilla, J., & Santibañez, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4033-2 · Cited by 58
Proteomic approaches to the study of papillomavirus-host interactions
White, E. A., & Howley, P. M. (2013) · Virology · doi:10.1016/j.virol.2012.09.046 · Cited by 57
Metadata
- Authors
- Gillison, M. L., Chaturvedi, A. K., & Lowy, D. R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-11-03
- Volume
- 113
- Issue
- S10
- Pages
- 3036-3046
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2048536455
- Cited by
- 517
- References
- 57
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.